Zydus Inspection 2025: VAI Revised

  Published 8 months ago

Inspection (June 9‑18, 2025) revised facility from OAI to VAI; Zydus Lifesciences develops global therapies.

  • The inspection period spanned ten days, assessing compliance, safety, and operational practices at the facility overall
  • 2024 classification indicated Official Action Required; 2025 revision downgraded to voluntary corrective measures for compliance
  • Zydus Lifesciences focuses on the discovery, development, manufacturing, and marketing of diverse healthcare therapies worldwide today

You might like these

Air India Crash Sparks Insurance Claims, Shares Drop

Wipro Q2 FY26 Revenue, Bookings, Outlook

Vikram Solar Wins Sunsure Deal

JK Cement Launches Eco-Friendly LC-3

APSEZ Ports Report Record Cargo Growth in Q1 FY26

NTPC Green Energy Project Milestones

Claude Models Now Available on Google Vertex AI

News that matters the most ⚡